PTC Therapeutics Inc. (PTCT) Has Jumped To A New High On Study News
PTC Therapeutics Inc. (PTCT) presented interim data from Part 1 of the FIREFISH study of risdiplam in babies with Type 1 Spinal Muscular Atrophy, at the SMA Researcher Meeting over the weekend.
Source: RTTNews